© PHIRE | All rights reserved
High-grade non-muscle invasive urothelial carcinoma in dogs and humans share specific expression of integrin α5β1
Authors
Roberta Lucianò, Maurizio Colecchia, Francesca Sanvito, Irene Locatelli, Chiara Venegoni, Alessia Di Coste, Davide Danilo Zani, Angelica Stranieri, Chiara Giudice, Antonella Rigillo, Matteo Gambini, Francesco Montorsi, Andrea Salonia, Marco Moschini, Massimo Alfano
Abstract
Urothelial carcinoma (UC) accounts for more than 90% of all bladder cancers both in humans and dogs. Human and canine UC share many genetic mutations and tumor markers and clinical and therapeutic interventions. The unmet clinical needs are similar such as the early detection and treatment of the high-grade residual disease responsible for tumor recurrence and progression. The aim of this study was to investigate the expression of the α5β1 integrin and its specificity in high-grade UC in humans and dogs, a marker recently reported in the human bladder in situ carcinoma and murine model of orthotopic bladder cancer.
